Beta blockers are associated with increased risk of cardiovascular events after surgeryBMJ 2015; 351 doi: https://doi.org/10.1136/bmj.h5349 (Published 07 October 2015) Cite this as: BMJ 2015;351:h5349
- Jacqui Wise
A large Danish study, published in JAMA Internal Medicine, has found that treatment with beta blockers was associated with a statistically significant increase in the rate of major adverse cardiovascular events and death within 30 days of non-cardiac surgery.1
The use of beta blockers during non-cardiac surgery is currently being re-evaluated because of concerns over the validity of some previous studies. Guidelines in the United States and Europe recommend continuing …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial